| Literature DB >> 34579188 |
Juan P Aguilar Ticona1,2, Nivison Nery1,2, Renato Victoriano2, Mariam O Fofana3, Guilherme S Ribeiro2,4, Emanuele Giorgi5, Mitermayer G Reis2,3,4, Albert I Ko2,3, Federico Costa1,2,3.
Abstract
Slum residents are more vulnerable to COVID-19 infection. Without a specific treatment, vaccination became the main strategy against COVID-19. In this study, we determined the rate and factors associated with the willingness to get vaccinated against COVID-19 among slum residents and their main reasons associated with the vaccine intention. The study was conducted in Pau da Lima, a slum community in Salvador Brazil. In total, 985 residents were interviewed. Among them 66.0% (650/985) were willing to get vaccinated, 26.1% (257/985) were hesitant to take the vaccine and 7.9% (78/285) were not sure. The main reasons cited for vaccine hesitancy or being unsure were concerns about vaccine efficacy and potential side effects. In contrast, the main reasons cited for wanting the vaccine were the high incidence of COVID-19 cases and participants' self-perception of their own health history. Multivariate analysis identified that COVID-19 vaccine hesitancy was associated with younger age and low social capital, summarized as low perceived importance of vaccination to protect one's family, friends and community. Slum residents have been less willing to vaccinate than the general population. Social capital presents a critical opportunity in the design of communication campaigns to increase COVID-19 vaccine acceptance in slum settings.Entities:
Keywords: COVID-19; vaccine; vaccine hesitancy
Year: 2021 PMID: 34579188 PMCID: PMC8472908 DOI: 10.3390/vaccines9090951
Source DB: PubMed Journal: Vaccines (Basel) ISSN: 2076-393X
Participants’ demographic characteristics and COVID-19 diagnoses and exposures among Pau da Lima residents and willingness to receive COVID-19 vaccination.
| Characteristic | No. | Survey Sample 1 | Willingness to Receive a COVID-19 Vaccine 2 | ||||
|---|---|---|---|---|---|---|---|
| Yes ( | Not Sure ( | No ( | |||||
| Mean (SD) or | |||||||
| Demographic characteristics | |||||||
| Age in years | 985 | 39 (14) | 40 (15) | 38 (15) | 35 (13) | 0.4 | <0.001 |
| Gender | 0.33 | 0.43 | |||||
| Male | 985 | 394 (40) | 258 (65) | 26 (6.6) | 110 (28) | ||
| Female | 985 | 591 (60) | 392 (66) | 52 (8.8) | 147 (25) | ||
| Ethnicity | 0.057 | 0.47 | |||||
| Black | 985 | 531 (54) | 354 (67) | 37 (7.0) | 140 (26) | ||
| Brown | 985 | 396 (40) | 261 (66) | 34 (8.6) | 101 (26) | ||
| White | 985 | 51 (5.2) | 33 (65) | 5 (9.8) | 13 (25) | ||
| Others | 985 | 7 (0.7) | 2 (29) | 2 (29) | 3 (43) | ||
| Schooling | 0.39 | 0.63 | |||||
| 0–6 years | 985 | 342 (35) | 226 (66) | 31 (9.1) | 85 (25) | ||
| ≥7 years | 985 | 643 (65) | 424 (66) | 47 (7.3) | 172 (27) | ||
| Married or stable union | 0.92 | 0.44 | |||||
| Yes | 985 | 358 (36) | 242 (68) | 28 (7.8) | 88 (25) | ||
| No | 985 | 627 (64) | 408 (65) | 50 (8.0) | 169 (27) | ||
| Employment | 0.21 | 0.018 | |||||
| Formal | 985 | 309 (31) | 190 (61) | 27 (8.7) | 92 (30) | ||
| Informal | 985 | 182 (18) | 137 (75) | 10 (5.5) | 35 (19) | ||
| Unemployed | 985 | 494 (50) | 323 (65) | 41 (8.3) | 130 (26) | ||
| Per capita daily household income (USD) | 985 | 5.2 (5.5) | 5.6 (5.8) | 4.1 (4.6) | 4.5 (5.0) | 0.011 | 0.007 |
| Lost employment during pandemic | 0.008 | 0.62 | |||||
| Yes | 952 | 400 (42) | 278 (70) | 19 (4.8) | 103 (26) | ||
| No | 952 | 552 (58) | 356 (64) | 52 (9.4) | 144 (26) | ||
| Underlying medical condition 4 | 0.38 | 0.01 | |||||
| Yes | 985 | 216 (22) | 159 (74) | 15 (6.9) | 42 (19) | ||
| Received influenza vaccine in 2020 | 0.004 | <0.001 | |||||
| Yes | 665 | 253 (38) | 186 (74) | 18 (7.1) | 49 (19) | ||
| No | 665 | 412 (62) | 235 (57) | 53 (13) | 124 (30) | ||
| No | 985 | 769 (78) | 491 (64) | 63 (8.2) | 215 (28) | ||
| COVID-19 diagnoses and exposures | |||||||
| Episode of COVID-19 symptoms | 0.14 | 0.57 | |||||
| Yes | 985 | 110 (11) | 73 (66) | 4 (3.6) | 33 (30) | ||
| No | 985 | 875 (89) | 577 (66) | 74 (8.5) | 224 (26) | ||
| Clinical suspicion of COVID-19 | >0.99 | 0.55 | |||||
| Yes | 982 | 31 (3.2) | 22 (71) | 3 (9.7) | 6 (19) | ||
| No | 982 | 951 (97) | 627 (66) | 75 (7.9) | 249 (26) | ||
| Tested for COVID-19 | 0.046 | 0.068 | |||||
| Yes | 985 | 149 (15) | 112 (75) | 6 (4.0) | 31 (21) | ||
| No | 985 | 836 (85) | 538 (64) | 72 (8.6) | 226 (27) | ||
| Household member with suspected COVID-19 | 0.19 | >0.99 | |||||
| Yes | 619 | 76 (12) | 53 (70) | 3 (3.9) | 20 (26) | ||
| No | 619 | 543 (88) | 358 (66) | 50 (9.2) | 135 (25) | ||
| Household member with confirmed COVID-19 | >0.99 | 0.65 | |||||
| Yes | 615 | 18 (2.9) | 11 (61) | 1 (5.6) | 6 (33) | ||
| No | 615 | 597 (97) | 396 (66) | 52 (8.7) | 149 (25) | ||
| Received molecular testing | 0.19 | 0.008 | |||||
| Yes | 983 | 70 (7.1) | 58 (83) | 3 (4.3) | 9 (13) | ||
| No | 983 | 913 (93) | 591 (65) | 75 (8.2) | 247 (27) | ||
| Positive molecular test result among tested | >0.99 | 0.92 | |||||
| Yes | 70 | 13 (19) | 11 (85) | 1 (7.7) | 1 (7.7) | ||
| No | 70 | 57 (81) | 47 (82) | 2 (3.5) | 8 (14) | ||
| Received serological testing | 0.12 | 0.92 | |||||
| Yes | 980 | 91 (9.3) | 64 (70) | 3 (3.3) | 24 (26) | ||
| No | 980 | 889 (91) | 583 (66) | 75 (8.4) | 231 (26) | ||
| Positive serologic test result among tested | 0.11 | >0.99 | |||||
| Yes | 91 | 14 (15) | 9 (64) | 2 (14) | 3 (21) | ||
| No | 91 | 77 (85) | 55 (71) | 1 (1.3) | 21 (27) | ||
1 Survey sample column was summarized using column percentages; 2 Willingness to take COVID-19 vaccine columns were summarized using row percentages; t-test or Pearson’s Chi-squared test; 4 Hypertension, diabetes and cancer.
Figure 1Reasons provided by participants regarding willingness to receive a COVID-19 vaccine. (A) Among participants who demonstrated willingness to get vaccinated; (B) among participants who were unsure about vaccination; (C) among participants who hesitant to take the COVID-19 vaccine.
Attitudes related to COVID-19 risk and vaccination among Pau da Lima residents and the willingness to receive COVID-19 vaccination.
| Characteristic | No. | Survey Sample 1 | Willingness to Receive a COVID-19 Vaccine 2 | ||||
|---|---|---|---|---|---|---|---|
| Yes ( | Not Sure ( | No ( | |||||
| Mean (SD) or | |||||||
| How likely are you to get COVID-19? | 0.42 | 0.021 | |||||
| Very likely | 985 | 240 (24) | 169 (70) | 16 (6.7) | 55 (23) | ||
| Moderately likely | 985 | 225 (23) | 154 (68) | 18 (8.0) | 53 (24) | ||
| Slightly likely | 985 | 222 (23) | 141 (64) | 23 (10) | 58 (26) | ||
| Not likely | 985 | 164 (17) | 92 (56) | 13 (7.9) | 59 (36) | ||
| Do not know | 985 | 134 (14) | 94 (70) | 8 (6.0) | 32 (24) | ||
| How severe would your condition be if you contracted COVID-19? | 0.041 | 0.011 | |||||
| Very severe | 985 | 242 (25) | 169 (70) | 9 (3.7) | 64 (26) | ||
| Moderately severe | 985 | 155 (16) | 102 (66) | 18 (12) | 35 (23) | ||
| Slightly severe | 985 | 216 (22) | 142 (66) | 22 (10) | 52 (24) | ||
| Not severe | 985 | 152 (15) | 83 (55) | 12 (7.9) | 57 (38) | ||
| Do not know | 985 | 220 (22) | 154 (70) | 17 (7.7) | 49 (22) | ||
| How important is vaccination to protect family/friends? | <0.001 | <0.001 | |||||
| Extremely important | 821 | 311 (38) | 256 (82) | 24 (7.7) | 31 (10.0) | ||
| Very important | 821 | 374 (46) | 253 (68) | 22 (5.9) | 99 (26) | ||
| Moderately important | 821 | 41 (5.0) | 12 (29) | 9 (22) | 20 (49) | ||
| Slightly important | 821 | 33 (4.0) | 6 (18) | 11 (33) | 16 (48) | ||
| Not important | 821 | 62 (7.6) | 4 (6.5) | 12 (19) | 46 (74) | ||
| How important is vaccination to protect the health of your community? | <0.001 | <0.001 | |||||
| Extremely important | 821 | 295 (36) | 244 (83) | 22 (7.5) | 29 (9.8) | ||
| Very important | 821 | 364 (44) | 252 (69) | 21 (5.8) | 91 (25) | ||
| Moderately important | 821 | 46 (5.6) | 15 (33) | 9 (20) | 22 (48) | ||
| Slightly important | 821 | 48 (5.8) | 10 (21) | 15 (31) | 23 (48) | ||
| Not important | 821 | 68 (8.3) | 10 (15) | 11 (16) | 47 (69) | ||
| Would you vaccinate your children if safe and effective? 4 | 402 | <0.001 | <0.001 | ||||
| Yes | 402 | 270 (67) | 224 (83) | 20 (7.4) | 26 (9.6) | ||
| No | 402 | 73 (18) | 12 (16) | 4 (5.5) | 57 (78) | ||
| Do not know | 402 | 59 (15) | 17 (29) | 22 (37) | 20 (34) | ||
1 Survey sample column was summarized using column percentages; 2 Willingness to take COVID-19 vaccine columns were summarized using row percentages; t-test or Pearson’s Chi-squared test. 4 Information available only for parents; the variation in number of responses between variables reflects the availability of specific information.
Figure 2Multinomial regression model of factors associated with COVID-19 vaccine hesitancy. (A) Not Sure vs. Yes (B) No vs. Yes.